Patents Assigned to The University Hospital
-
Patent number: 11795224Abstract: The present disclosure provides an anti-T-cell nanobody that specifically binds to CD3 ?. The present disclosure also provides the nucleic acid sequence of the anti-T-cell nanobody, use of the anti-T-cell nanobody for treating cancer, immunoregulation and activating immune cells, and a method for detecting expression levels of CD3 ?.Type: GrantFiled: March 18, 2022Date of Patent: October 24, 2023Assignee: CHINA MEDICAL UNIVERSITY HOSPITALInventors: Der-Yang Cho, Shao-Chih Chiu, Shi-Wei Huang, Chih-Ming Pan, Mei-Chih Chen, Yu-Chuan Lin, Yeh Chen
-
Publication number: 20230330179Abstract: A composition suitable for preventing or treating an inflammatory disease is disclosed. The composition contains zinc finger protein with KRAB and SCAN domains 8 (Zkscan8) protein, which has a superior effect of effectively inhibiting inflammatory responses by inhibiting the expression of inflammatory cytokines and promoting the expression of anti-inflammatory factors. Therefore, the composition can be effectively used for preventing or treating an inflammatory disease.Type: ApplicationFiled: July 2, 2021Publication date: October 19, 2023Applicant: SEOUL NATTIONAL UNIVERSITY HOSPITALInventors: Hyun Chul JO, Ah-Young LEE, JI-Hye YEA
-
Patent number: 11785922Abstract: Provided are a protein complex in which estrogen receptor 2 (-ERT2) is fused to CRISPR associated protein 9 (Cas9), and a recombinant vector carrying a gene coding the protein complex, wherein ERT2 is bonded to the N-terminus and C-terminus of nuclear localization sequence (NLS)-removed Cas9 and the complex has the advantage of translocating from the cytosol into the nucleus at a certain time point upon treatment with tamoxifen and modifying a specific DNA with the aid of guide RNA (gRNA), ultimately enabling a more elaborate DNA modification operation in a desired part at a desired time point.Type: GrantFiled: May 3, 2018Date of Patent: October 17, 2023Assignee: SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Eun Ju Lee, Hyo-Soo Kim
-
Patent number: 11779222Abstract: The disclosure provides a method of and an imaging system for clinical sign detection. The method uses an imaging system having an RGB image sensor and the processing device disclosed herein. An image of a patient or examinee is captured by the RGB image sensor to generate an RGB image. Clinical signs of the patient or examinee are detected by the processing device based on the RGB images.Type: GrantFiled: July 9, 2020Date of Patent: October 10, 2023Assignees: COMPAL ELECTRONICS, INC., National Taiwan University HospitalInventors: Tung-Hung Su, Cheng-Fu Chou, Shann-Ching Chen
-
Patent number: 11771318Abstract: The present invention relates to a method for supporting reading of a fundus image of a subject, and a computing device using the same. Specifically, the computing device according to the present invention acquires the fundus image of the subject, extracts attribute information from the fundus image on the basis of a machine learning model for extracting the attribute information of the fundus image, and provides the extracted attribute information to an external entity. In addition, when evaluation information on the extracted attribute information or modification information on the attribute information is acquired, the computing device according to the present invention can also update the machine learning model on the basis of the acquired evaluation information or modification information.Type: GrantFiled: July 18, 2018Date of Patent: October 3, 2023Assignees: VUNO, INC., SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Sang Jun Park, Joo Young Shin, Jae Min Son, Sang Keun Kim, Kyuhwan Jung, Hyun-Jun Kim
-
Patent number: 11774388Abstract: As one example, an apparatus includes a dielectric microsensor having a microfluidic chamber that includes a capacitive sensing structure. The microfluidic chamber is adapted to receive a volume of a blood sample, and a bioactive agent is adapted to interact with the blood sample, as a sample under test (SUT), within the microfluidic chamber. A transmitter can provide an input radio frequency (RF) signal to the dielectric microsensor, and a receiver can receive an output RF signal from the dielectric microsensor. A computing device is configured to compute dielectric permittivity values for the SUT based on the output RF signal over a time interval in which the dielectric permittivity values are representative of the bioactive agent interacting with the blood sample over the time interval. The computing device is further configured to provide a readout representative of hemostatic dysfunction for the blood sample based on the dielectric permittivity values.Type: GrantFiled: June 29, 2022Date of Patent: October 3, 2023Assignees: CASE WESTERN RESERVE UNIVERSITY, UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTERInventors: Pedram Mohseni, Lalitha Nayak, Michael Suster, Sina Pourang
-
Publication number: 20230296583Abstract: Provided are an apparatus for diagnosing a disease and a method for diagnosing same. The apparatus includes a pump for pumping respiratory gas, a first pre-treatment portion connected to the pump and removing moisture and bad breath in the respiratory gas, and a volatile organic compound detector connected between the first pre-treatment portion and the pump and detecting volatile organic compounds in the respiratory gas.Type: ApplicationFiled: October 31, 2022Publication date: September 21, 2023Applicants: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE, SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Dae-Sik LEE, Sang Hoon JHEON, Hyung-Kun LEE, Yoohwa HWANG, Doyeob KIM, Chang-Beom KIM, Jin Oh LEE
-
Patent number: 11759330Abstract: The present invention provides a supporting member and a supporting member assembly including the same to be implanted into or between a subject's bones, and a template plug and a tamper corresponding to the supporting member. The supporting member comprises a main body; a first connecting portion and a second connecting portion formed on the upper and lower sides of the main body respectively and forming a dovetail joint with each other; and a guiding structure formed at a side of the main body and including guiding holes as well as a buffer groove for mating with an external template plug. The supporting members of the invention can be sequentially implanted and connected into a bone or between two connected bones, and improve the defect of the conventional one-size giant implants injuring the surrounding nerves.Type: GrantFiled: November 16, 2020Date of Patent: September 19, 2023Assignee: NATIONAL TAIWAN UNIVERSITY HOSPITAL JINSHAN BRANCHInventor: Jui-Yang Hsieh
-
Publication number: 20230288582Abstract: The disclosure relates to a device for detecting therapeutic radiation based on an optical disk with solar cells. The radiation detecting device may include at least one optical disk formed of a water-equivalent material, disposed perpendicular to a first direction in which the radiation is incident, and converting the radiation into visible light; a solar cell disposed on one side of the at least one optical disk, converting the visible light into an electrical signal; and a processing module for collecting and processing the electrical signal outputted from the solar cell.Type: ApplicationFiled: March 10, 2023Publication date: September 14, 2023Applicants: NATIONAL CANCER CENTER, SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Dongho SHIN, Tae Hyun KIM, Tae-Ho KIM, Haksoo KIM, Dong-Seok SHIN, Se Byeong LEE, Youngkyung LIM, Jonghwi JEONG, Jaeman SON
-
Patent number: 11744461Abstract: The present disclosure relates to a retina imaging method in which a light from a light source into two lights is dispersed, at least one eyeground image of the eyeball at a first magnification is obtained by adjusting the paths of the two lights incident on the eyeball, and a plurality of DIC images are obtained at a second magnification higher than the first magnification with respect to the retina of the entirety of the obtained at least one eyeground image by adjusting the paths of the two lights incident on the eyeball.Type: GrantFiled: February 26, 2020Date of Patent: September 5, 2023Assignees: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, SEOUL NATIONAL UNIVERSITY HOSPITAL, INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATIONInventors: Jae Hun Kim, Dae Yu Kim, Seok Hwan Kim, Youngho Cho, Byeongho Park, Hyo-suk Kim, Subeen Park, Kyoung Min Lee
-
Patent number: 11737917Abstract: An eye drop bottle storage unit for eye drop administration compliance includes a memory, a processor, and one or a plurality of eye drop bottle pods, where each eye drop bottle pod of the one or said plurality of eye drop bottle pods is configured to hold an eye drop bottle, and comprises one or a plurality of sensors. The memory is configured to store data of an eye drop administration regime of a subject. The processor is configured to receive signals from the one or said plurality of sensors of each eye drop bottle pod, and to determine from the received signals whether the subject administered eye drops into eyes of the subject from each eye drop bottle respectively held in each eye drop bottle pod of the one or said plurality of eye drop bottle pods in accordance with the eye drop administration regime data.Type: GrantFiled: August 17, 2018Date of Patent: August 29, 2023Assignees: NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD, NATIONAL UNIVERSITY OF SINGAPOREInventors: Victor Teck Chang Koh, Muhammad Azri Bin Razali, Teri Danielle You Ying Yeoh, Min Li Tey, Hui Chen Charmaine Chai, Yien Lai
-
Patent number: 11725248Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.Type: GrantFiled: April 20, 2017Date of Patent: August 15, 2023Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch, Julius-Maximilians-University of Würzburg, Oregon Health & Science University, Hospital Clinic de Barcelona, Universitat de Barcelona, Oslo University Hospital HF, The Cleveland Clinic Foundation, Mayo Foundation for Medical Education and ResearchInventors: Louis M. Staudt, David William Scott, George W. Wright, Andreas Rosenwald, Pau Abrisqueta, Rita Braziel, Elias Campo Guerri, Wing C. Chan, Joseph M. Connors, Jan Delabie, Diego Villa, Kai Fu, Randy D. Gascoyne, Timothy Greiner, Elaine S. Jaffe, Pedro Jares, Anja Mottok, German Ott, Lisa M. Rimsza, Graham Slack, Dennis Weisenburger, Erlend B. Smeland, James Robert Cook
-
Publication number: 20230248665Abstract: Provided is a composition comprising a dimethylchalcone derivative for prevention or treatment of metabolic diseases and, more specifically, to a compositioncomprising a derivative of 2?,4?-dihydroxy-6?-methoxy-3?,5?-dimethylchalcone as an active ingredient for the alleviation, prevention, or treatment of various metabolic diseases.Type: ApplicationFiled: March 16, 2023Publication date: August 10, 2023Applicants: SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION, SEOUL NATIONAL UNIVERSITY HOSPITAL, CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Kyong Soo PARK, Sung Soo CHUNG, Ji Seon LEE, Kwang Yong PARK
-
Patent number: 11719778Abstract: Methods and systems generate synthetic late gadolinium enhancement (LGE) magnetic resonance images using a magnetic resonance fingerprinting (MRF) acquisition. From a single acquisition, MRF image data is obtained, including co-registered T1 and T2 tissue property maps. Different tissue regions of interest are identified, such as viable myocardium, scar, and blood and T1 and T2 values for each are determined. Based on these, different sets of pulse sequence parameters are determined, e.g., using different synthetic image contrast models receiving the MRF image data. Synthetic LGE images at different contrasts are generated as a result, including a synthetic bright-blood LGE image, a synthetic dark-blood/gray-blood LGE image, and a synthetic optimized imaged.Type: GrantFiled: January 31, 2022Date of Patent: August 8, 2023Assignees: REGENTS OF THE UNIVERSITY OF MICHIGAN, CASE WESTERN RESERVE UNIVERSITY, UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTERInventors: Jesse Hamilton, Imran Rashid, Nicole Seiberlich, Sanjay Rajagopalan
-
Publication number: 20230242643Abstract: Chimeric antigen receptor (CAR) bridging protein are provided comprising a CAR-binding domain linked to an antigen-binding domain, which can be used to re-direct the targeting of CAR-T cells. The bridging protein may comprie an antigen-binding domain that targets any antigen of interest, such as, for example, a tumor antigen or viral antigen. Also provided are methods of using the bridging proteins in combination with CAR-T cells to treat a disease, such as, for example, a cancer or an infectious disease.Type: ApplicationFiled: May 27, 2021Publication date: August 3, 2023Applicants: ANTION BIOSCIENCES SA, GENEVA UNIVERSITY HOSPITALS, UNIVERSITY OF GENEVA, UNIVERSITY OF ZURICHInventors: Marco ALESSANDRINI, Karl-Heinz KRAUSE, Renier MYBURGH
-
Publication number: 20230235405Abstract: A marker composition, a kit, a gene panel, and a method which are for providing information for predicting the occurrence of, diagnosing, or treating age-related macular degeneration are disclosed. The marker composition, kit, gene panel, and method are novel tools that can provide information for predicting the occurrence of, diagnosing, or treating age-related macular degeneration, and has excellent sensitivity and can be easily analyzed without the use of a biopsy, and thus can be effectively used for the early diagnosis of age-related macular degeneration.Type: ApplicationFiled: February 21, 2023Publication date: July 27, 2023Applicants: Genome Opinion Inc., Seoul National University HospitalInventors: Choong Hyun Sun, Su Gyeong Kim, Ho Gune Im, Han Song, Baek Lok Oh, Su-Yeon Choi
-
Publication number: 20230235402Abstract: A composition suitable for diagnosing a musculoskeletal disease and a composition suitable for preventing or treating a musculoskeletal disease are disclosed. The composition contains zinc finger protein with KRAB and SCAN domains 8 (Zkscan8) protein, which can be effectively used as an excellent biomarker for obtaining accurate information about the occurrence and progression stages of a musculoskeletal disease, specifically a tendon disease or a ligament disease. The compositions containing Zkscan8 can be effectively used for preventing or treating a musculoskeletal disease through Zkscan8 overexpression.Type: ApplicationFiled: July 2, 2021Publication date: July 27, 2023Applicants: SEOUL NATIONAL UNIVERSITY HOSPITAL, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, CHEONGJU UNIVERSITY INDUSTRY & ACADEMY COOPERATION FOUNDATIONInventors: Hyun Chul JO, Young-il HWANG, Jin-Hee KIM, Jin-Hong KIM, Jae-Hyung LEE, Hyun-Ju LIM, Ah-Young LEE, Seung Yeon LEE, Ji-Hye YEA, Yeasol KIM
-
Publication number: 20230226201Abstract: The present invention relates to a unit drug conjugate wherein a binding group capable of binding to another unit drug conjugate is additionally linked to a unit drug conjugate in which a targeting substance, which binds specifically to target cells, and a drug, are linked together. When the unit drug conjugates according to the present invention are sequentially administered in vivo, complexes form a cluster by in vivo crosslinking, and the cluster promotes endocytosis of the drug conjugate, thereby significantly enhancing cellular internalization of the drug included in the drug conjugate.Type: ApplicationFiled: June 1, 2021Publication date: July 20, 2023Applicants: BIK THERAPEUTICS INC., SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Sang Eun KIM, Byung Chul LEE, Hewon YOUN, Ji Young CHOI, Jae Ho JUNG, In Ho SONG
-
Publication number: 20230211009Abstract: A method for producing exosomes in a large-scale by using a cyclic tensile bioreactor to stimulate cells to release exosomes. In addition, the exosome having an anti-HLA-G protein specific for cancer is used as a delivery vehicle to deliver therapeutic agents for treating cancer.Type: ApplicationFiled: December 2, 2022Publication date: July 6, 2023Applicants: CHINA MEDICAL UNIVERSITY, China Medical University Hospital, Shine-On Biomedical Co., Ltd.Inventors: Yi-Wen Chen, Der-Yang Cho, Hsin-Yuan Fang, Ming-You Shie, Chih-Ming Pan, Kai-Wen Kan, Cheng-Yu Chen, Min-Hua Yu, Shao-Chih Chiu
-
Patent number: 11690727Abstract: The present disclosure relates to an artificial ankle joint tibial component and, more particularly, to an artificial ankle joint tibial component of an implant that is implanted into a body, the implant including: a body part having a contact surface in contact with a resected surface of a distal end of a tibia of a joint and a joint surface facing a joint; and a fixing part formed to extend a predetermined length upwards from the contact surface, wherein the fixing part is configured as a single body formed to extent a predetermined length upwards from the center in the front area of the contact surface and includes a wing extending to one side, and wherein the wing includes at least one posterior wing that extends at a predetermined angle relative to an AP line, thereby preventing stress from being concentrated on one wing to avoid a fracture thereof and increasing the contact area between a bone and an implant to strengthen fixing force, prevent rotation, and disperse stress, so that bone resorption arounType: GrantFiled: August 28, 2018Date of Patent: July 4, 2023Assignees: CORENTEC CO., LTD., CHONNAM NATIONAL UNIVERSITY HOSPITAL, INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITYInventors: Keun-Bae Lee, Tae-Jin Shin